Funder: National Institutes of Health
Due Dates: February 24, 2025 | February 23, 2026 (New/Renewal/Resubmission/Revision)
Funding Amounts: Phase I: up to $350,000/year (1 year) | Phase II: up to $2.15M/year (2 years)
Summary: Supports U.S. small businesses developing miniaturized, automated tissue chip systems to advance drug development and biomedical research through higher throughput, automation, and commercialization pathways.
Key Information: Clinical trials are not allowed; only U.S. small businesses are eligible; milestone-driven cooperative agreement with NIH staff involvement.